About S3V Vascular Technologies
S3V Vascular Technologies is a company based in Mysuru (India) founded in 2011 by Vijaya Gopal Nagaradagadde and Badari Narayan. S3V Vascular Technologies has raised $41.9 million across 8 funding rounds from investors including Careernet, Refex Capital and Marvelinvestments. The company has 44 employees as of April 09, 2024. S3V Vascular Technologies operates in a competitive market with competitors including Elixir Medical, Global Vascular, Medfavour and iVascular, among others.
- Headquarter Mysuru, India
- Employees 44 as on 09 Apr, 2024
- Founders Vijaya Gopal Nagaradagadde, Badari Narayan
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name S3v Vascular Technologies Limited
- Date of Incorporation 09 Aug, 2011
- Jurisdiction Mysuru, Karnataka, India
-
Annual Revenue
$2.54 M (USD)26.99as on Mar 31, 2022
-
Net Profit
$323.85 K (USD)56.32as on Mar 31, 2022
-
EBITDA
$676.01 K (USD)51.49as on Mar 31, 2022
-
Total Equity Funding
$41.9 M (USD)
in 8 rounds
-
Latest Funding Round
$36.21 M (USD), Series B
Mar 14, 2024
-
Investors
Careernet
& 129 more
-
Employee Count
44
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of S3V Vascular Technologies
S3V Vascular Technologies has successfully raised a total of $41.9M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $36.21 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in S3V Vascular Technologies
S3V Vascular Technologies has secured backing from 130 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Careernet, Refex Capital and Marvelinvestments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Locked | Locked | Locked | |
|
Early-stage venture capital fund investing in innovative startups.
|
Locked | Locked | Locked | |
|
Recruitment and talent management services are provided to businesses.
|
Locked | Locked | Locked |
Investor details for S3V Vascular Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by S3V Vascular Technologies
Investment portfolio details for S3V Vascular Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - S3V Vascular Technologies
Detailed financials for S3V Vascular Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
S3v Vascular Technologies Comparisons
Peer comparison for S3V Vascular Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of S3V Vascular Technologies
S3V Vascular Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Elixir Medical, Global Vascular, Medfavour and iVascular, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug eluting stents
|
|
| Locked | Locked | Locked |
Drug-eluting stent systems for lower limb artery disease are developed.
|
|
| Locked | Locked | Locked |
Develops innovative technologies for drug-eluting stents to treat cardiac disorders.
|
|
| Locked | Locked | Locked |
Develops vascular medical devices for coronary, peripheral, and neurointerventionism treatments.
|
Detailed competitors of S3V Vascular Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on S3v Vascular Technologies
Complete news archive for S3V Vascular Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about S3V Vascular Technologies
S3V Vascular Technologies was founded in 2011 and raised its 1st funding round 1 year after it was founded.
S3V Vascular Technologies is headquartered in Mysuru, India. It is registered at Mysuru, Karnataka, India.
S3V Vascular Technologies is a funded company, having raised a total of $41.9M across 8 funding rounds to date.
As of Apr 09, 2024, the latest employee count at S3V Vascular Technologies is 44.
Annual revenue of S3V Vascular Technologies is $2.54M as on Mar 31, 2022.
Founded in 2011 in Mysuru, India, S3V Vascular Technologies operates in the medical devices sector. Cardiovascular surgical and critical care devices are developed, with a focus on cardiac stents, clot retrievers, and catheters. Specific products include the coronary stent implantation system, drug eluting stent system, aspiration catheter, and balloon dilatation catheter. Operations center on innovation in vascular technologies for clinical applications.
S3V Vascular Technologies's top competitors include Global Vascular, Elixir Medical and Medfavour.
S3V Vascular Technologies has 130 investors. Key investors include Careernet, Refex Capital, Marvelinvestments, Dugar Finance And Investments, and A M Naik.
The valuation of S3V Vascular Technologies is $29.14M as of Feb 2023.